Process
Managing over 70,000 patients
Nation's fastest growing
in-home self-testing PT/INR
What is MdINR?
Why MdINR?
TURN AROUND TIME
MEDICARE ORDERS SHIPPING WITHIN 24-48 HOURS
LOCAL
LICENSED CLINICIAN FOR IN HOME INSTRUCTION
Nation wide company
FACE TO FACE TRAINING
Advantages
RELATIONSHIP
COMMUNICATION
LIVE PERSON TO ANSWER QUESTIONS
Recent studies have shown:
In Home-Testing
There was no evidence that self-testing was harmful, and patient satisfaction was modestly better with this intervention
Step 1:
Step 3
Research has shown that home-testing of the INR leads to better anticoagulant control and improved quality of life
Patient is identified as a candidate for in home testing and meets all of the eligibility requirements
Step 2:
Clinician is sent out to the patients home and trains the patient on how to use their device or training may be done in the clinic as well
A Lincare company
Order is placed and an MdINR representative communicates with patient the insurance coverage.
Device and supplies are shipped
Interactive voice-response reporting system provided a saftey net to prevent events resulting from delays in follow-up, which is likely to be important in minimizing operational failures of anticoagulation monitoring
Home testing is not an alternative to regular care provided by a medical practitioner; it allows practitioners to make more informed patient care decisions
Weekly Testing
Conclusion from recent studies on weekly self-testing:
Your patient is now ready to test in their home at your frequency you prescribed
- More INR values in therapeutic range
- Increase frequency without adding burden on patient or healthcare system
- Allows action to take place quicker than when compared with standard management
One of the major advantages of self testing at home is the possibility of increasing the frequency of testing without adding a great burden to the patient and to the healthcare system
Weekly testing allows action to be taken before the INR deviates too much and thus prevents strongly aberrant and widely fluctuating INR values.
Self-testing patients have a higher percentage of their INR values within the therapeutic range (84% vs 73%)
If patient has Medicare and no secondary insurance...
$26.54 One time (face-to-face training) - G0248
$24.43 Every 4 tests - G0249
Secondary covers the difference 90% of the time
$9-11.00 Physicians Interpretation of the test results - G0250
CoaguChek XS
- FDA approved
- Easy to use
- Saftey and reliable